A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Outcomes?
Status:
Terminated
Trial end date:
2016-04-08
Target enrollment:
Participant gender:
Summary
Randomized trial to evaluate impact of healthcare provider( clinician and nursing staff)
support and education on treatment discontinuation rates in the absence of progression in
patients with metastatic colorectal cancer treated with regorafenib. Intensified education
and support will be provided through an application for iPad which has automatic links to
grading, dose reduction and side effect management ,as well as, references for additional
articles.